Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Gleevec/Glivec

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gleevec/Glivec was produced by Novartis.

Novartis aims for 10 blockbuster launches by 2020

Novartis aims for 10 blockbuster launches by 2020

On the downside, revenues from post-patent expiry cancer drug Glivec continued to decline (down 20% to $1.56bn).

Biopharma's Future: Made in China

Biopharma's Future: Made in China Novartis’ leukaemia treatment Glivec.

Novartis gets speedy reviews for new Kymriah filings

Novartis gets speedy reviews for new Kymriah filings as Glivec (imatinib) are succumbing to generic competition.

Novartis Oncology head Bruno Strigini to retire

Novartis Oncology head Bruno Strigini to retire He has navigated the business unit through the Gleevec patent expiration and has led the successful integration of the GSK Oncology Product Portfolio acquired in 2015.

Novartis' orphan drug Tasigna wins EU expanded indication

Novartis' orphan drug Tasigna wins EU expanded indication Gilvec/Gleevec (imatinib).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics